Video
Complementary Strategies in Psoriasis.
IPC Councilor Dr. Fernando Valenzuela reviews non-pharmacological strategies for managing psoriasis, covering diet,…
IPC Councilor Dr. Fernando Valenzuela reviews non-pharmacological strategies for managing psoriasis, covering diet,…
Watch VideoEl Dr. Fernando Valenzuela, Consejero de IPC, repasa las estrategias no farmacológicas para el manejo de la psoriasis,…
Watch VideoKey takeaways from the 2025 EADV Congress in Paris, including the IPC Symposium on psoriasis, Free Communication…
View ReportIPC Councilor Dr. Fernando Valenzuela explains how phototherapy can be effectively used to treat psoriasis in pediatric…
Watch VideoEn este video de Take Ten con IPC, el Dr. Fernando Valenzuela analiza la conexión entre la salud oral y la psoriasis,…
Watch VideoIn this Take Ten with IPC video, Dr. Fernando Valenzuela explores the connection between oral health and psoriasis,…
Watch VideoEl Dr. Fernando Valenzuela analiza las ventajas y desventajas de la fototerapia como opción de tratamiento para…
Watch VideoREUNIÓN ANUAL DE DERMATÓLOGOS LATINOAMERICANOS (RADLA) | LIMA, PERÚ Tuesday, May 7 09:00– 12:00 PET Program…
IPC stands for accessible treatment and universal healthcare on World Psoriasis Day and beyond. Gain insights from…
Read MoreDr. Fernando Valenzuela discusses how he treats nail psoriasis in his daily practice. El Dr. Fernando Valenzuela…
Watch VideoThe IPC’s global network of experts generously volunteers their time every year to educate and train other physicians…
Read MoreREUNIÓN ANUAL DE DERMATÓLOGOS LATINOAMERICANOS (RADLA) | CURITIBA, BRAZIL Friday, May 26 14:00 – 17:00 BRT 13:00…
La XXXIX Reunión Anual de Dermatólogos Latinoamericanos (RADLA) se realizó de manera virtual del 2 al 5 de mayo,…
Read MoreIt is not fully understood the impact that COVID-19 has on psoriasis patients. .
Read MoreBiologics and biosimilars have created many new options in psoriasis treatment for patients worldwide, but patients…
Read MoreView Report
Latin American countries view biosimilar agents as an effective approach to curtail health-care expenditures while…
View Report| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
A new IPC paper in JAAD presents five priorities for improving metabolic screening, advancing GLP-1 research in the context of psoriasis, and defining the dermatologist’s role in managing cardiometabolic risk in psoriasis patients.
IPC Jr. Councilor Mio Nakamura speaks with Dr. John Koo about how personality traits, including borderline personality disorder, shape clinical interactions and shares practical strategies for dermatologists to build stronger patient relationships.
Recordings from the IPC Fellows Research Class #1: Global and Collaborative Research in Psoriasis are now available. Program Chairs Peter van de Kerkhof, MD, PhD, and María Julia Cura, MD, led a faculty of international experts through sessions on unresolved questions in the era of effective psoriasis therapies, building global research collaborations, and connecting psoriasis research across disciplines. Watch to hear from Wolf Henning Boehncke, MD, MA, Christopher Griffiths, OBE, MD, FMedSci, and Georg Stingl, MD, as they share perspectives shaping the next generation of psoriasis research.
The IPC Resource Library now includes a dedicated Research Skills category, bringing together videos, articles, and presentations focused on building stronger research capabilities in psoriasis. Browse the current collection to find resources on topics from collaborative research methods to career development for researchers at every stage.
Rare ADAR1 gene mutations drive a distinct, interferon-fueled psoriasis subtype, and it responds to JAK1 and TYK2 inhibitors rather than standard IL-17/IL-23 biologics.
IPC Councilor Anna Lopez Ferrer, MD, PhD, reviews PURE-4, a four-item tool that helps dermatologists screen psoriasis patients for psoriatic arthritis (PsA) risk. She traces its evolution across three studies (2018–2026) into a validated predictor of early PsA.
IPC Councilor André Lucas Ribeiro, MD, reframes PsA as a slow transition from psoriasis, not a sudden event, opening the door to disease interception. He outlines the steps needed to get there, from harmonizing definitions to reducing inflammatory burden.